VYYRF (Voyageur Pharmaceuticals) Stock Based Compensation: $0.33 Mil (TTM As of Feb. 2026)


VYYRF Voyageur Pharmaceuticals Ltd VYYRF
14 GF Score
Price $0.10
! 5 Warning Signs
View Full Analysis

What is Voyageur Pharmaceuticals Stock Based Compensation?

Voyageur Pharmaceuticals VYYRF 14 Stock Based Compensation is $0.33 Mil as of Feb. 2026. GuruFocus rates VYYRF with a GF Score™ of 14/100. The stock has 5 warning signs investors should review.

Voyageur Pharmaceuticals's Stock Based Compensation for the three months ended in Feb. 2026 was $0.03 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in Feb. 2026 was $0.33 Mil.

Voyageur Pharmaceuticals Stock Based Compensation Related Terms

Voyageur Pharmaceuticals Stock Based Compensation Historical Data

* Premium members only.

The historical data trend for Voyageur Pharmaceuticals's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Voyageur Pharmaceuticals Stock Based Compensation Chart

Voyageur Pharmaceuticals Annual Data
Trend Nov16 Nov17 Nov18 Nov19 Nov20 Nov21 Nov22 Nov23 Nov24 Nov25
Stock Based Compensation
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.59 0.15 0.17 0.30 0.58

Voyageur Pharmaceuticals Quarterly Data
May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25 May25 Aug25 Nov25 Feb26
Stock Based Compensation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.28 0.22 0.18 -0.09 0.03
VYYRF
14GF Score
Voyageur Pharmaceuticals Ltd VYYRF
Stock Based Compensation is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Voyageur Pharmaceuticals Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Stock Based Compensation for the trailing twelve months (TTM) ended in Feb. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.33 Mil.

What does a Stock Based Compensation of $0.33 Mil mean?
Voyageur Pharmaceuticals (VYYRF) has a Stock Based Compensation of $0.33 Mil as of Feb. 2026. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for Voyageur Pharmaceuticals and its competitors.
Is Voyageur Pharmaceuticals' Stock Based Compensation too high?
Voyageur Pharmaceuticals' current Stock Based Compensation is $0.33 Mil. Overall, Voyageur Pharmaceuticals has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.
How does Voyageur Pharmaceuticals' Stock Based Compensation compare to ZTS and UTHR?
Voyageur Pharmaceuticals' Stock Based Compensation of $0.33 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Stock Based Compensation for a Drug Manufacturers company?
A good Stock Based Compensation depends on the Drug Manufacturers industry context. However, Stock Based Compensation should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Stock Based Compensation mean?
A high Stock Based Compensation can signal that a stock is expensive relative to its fundamentals. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for Voyageur Pharmaceuticals and its competitors. Voyageur Pharmaceuticals's current Stock Based Compensation is $0.33 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Voyageur Pharmaceuticals stock overvalued right now?
Voyageur Pharmaceuticals (VYYRF) has a current Stock Based Compensation of $0.33 Mil. The current Stock Based Compensation is $0.33 Mil. Voyageur Pharmaceuticals' overall GF Score™ is 14/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Stock Based Compensation calculated?
Stock Based Compensation is calculated from a company's financial statements. For Voyageur Pharmaceuticals (VYYRF), the current Stock Based Compensation is $0.33 Mil as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Voyageur Pharmaceuticals Business Description

Other Exchanges VM:Canada
Address 4103B Center Street NW, Calgary, AB, CAN, T2E 2Y6
Voyageur Pharmaceuticals Ltd is a Canadian development-stage pharmaceutical company developing and selling barium and iodine active pharmaceutical ingredients (API) and high-performance, cost-effective imaging contrast agents for medical radiology. Its product portfolio comprises SmoothX (a barium sulfate suspension), SmoothHD, SmoothLD (a low-density barium suspension solution), VisionHD (a high-density barium powder suspension), VisionLD, V-Gas, and others. Additionally, the company has interests in two mineral properties: Frances Creek and Jubilee Mountain, located in the province of British Columbia, Canada, and the ULI Project in the state of Utah, United States of America.
14GF Score

Get the complete analysis for VYYRF

Stock Based Compensation is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.10
Price